Justin W. Yorke's most recent trade in Processa Pharmaceuticals Inc was a trade of 175,299 Restricted Stock done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 175,299 | 206,505 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 27 Jan 2025 | 12,400 | 12,400 | - | 0.8 | 9,889 | Common Stock |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,400 | 12,400 | - | - | Warrants | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,200 | 6,200 | - | - | Warrants | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 31,206 | 31,206 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Yorke Justin W. | Director | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 30 Jan 2024 | 8,000 | 31,232 | - | 2.7 | 21,544 | Common Stock |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 101,365 | 101,365 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 23,636 | 0 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 23,636 | 56,729 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 30,000 | 30,000 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 18,208 | 33,093 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 1,169 | 14,885 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 4,393 | 13,716 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 18,208 | 19,377 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Sale of securities on an exchange or to another person at price $ 3.30 per share. | 27 Jan 2022 | 1,854 | 532,563 | - | 3.3 | 6,118 | Common Stock |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,169 | 9,323 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 13 Apr 2021 | 9,700 | 248,272 | - | 9.4 | 91,374 | Common Stock |
| Processa Pharmaceuticals Inc | Justin W. Yorke | Director | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 13 Apr 2021 | 6,500 | 257,972 | - | 9.9 | 64,090 | Common Stock |